June 2024 Insights Into Three Swedish Stocks Estimated Below Value

In This Article:

Amidst a backdrop of political uncertainty and fluctuating markets across Europe, Sweden's equities market presents a unique landscape for investors seeking value. This article explores three Swedish stocks that appear undervalued in the current economic climate, offering potential opportunities for those looking to diversify their portfolios with international assets.

Top 10 Undervalued Stocks Based On Cash Flows In Sweden

Name

Current Price

Fair Value (Est)

Discount (Est)

Bj?rn Borg (OM:BORG)

SEK55.00

SEK101.85

46%

Boule Diagnostics (OM:BOUL)

SEK10.60

SEK20.95

49.4%

Alleima (OM:ALLEI)

SEK69.55

SEK138.36

49.7%

Nordic Waterproofing Holding (OM:NWG)

SEK161.80

SEK296.14

45.4%

Net Insight (OM:NETI B)

SEK5.05

SEK9.84

48.7%

Nolato (OM:NOLA B)

SEK58.85

SEK111.99

47.4%

MilDef Group (OM:MILDEF)

SEK70.70

SEK132.15

46.5%

Humble Group (OM:HUMBLE)

SEK9.85

SEK19.39

49.2%

Sinch (OM:SINCH)

SEK22.06

SEK40.52

45.6%

Gigasun (OM:GIGA)

SEK3.79

SEK7.49

49.4%

Click here to see the full list of 45 stocks from our Undervalued Swedish Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener

AcadeMedia

Overview: AcadeMedia AB (publ) is an independent education provider operating in Sweden, Norway, the Netherlands, and Germany with a market capitalization of SEK 5.43 billion.

Operations: The company generates revenue from several educational services, with SEK 6.20 billion from Upper Secondary Schools, SEK 6.07 billion from Preschool & International, SEK 4.25 billion in Compulsory School, and SEK 1.79 billion in Adult Education.

Estimated Discount To Fair Value: 29.7%

AcadeMedia, valued at SEK 53.5, is trading below its estimated fair value of SEK 76.11, indicating a potential undervaluation by 29.7%. The company's earnings and revenue growth are outpacing the Swedish market, with earnings expected to rise significantly over the next three years and revenue forecasted to grow at 9.5% annually compared to the market's 1.8%. However, it has an unstable dividend track record and its forecasted Return on Equity is low at 13.5%. Recent financials show a strong performance with year-over-year increases in sales and net income for both quarterly and nine-month periods.

OM:ACAD Discounted Cash Flow as at Jun 2024
OM:ACAD Discounted Cash Flow as at Jun 2024

CellaVision

Overview: CellaVision AB (publ) specializes in developing and selling instruments, software, and reagents for the analysis of blood and body fluids, operating both in Sweden and internationally, with a market capitalization of SEK 6.05 billion.